Mar 28, 2024 04:32PM
Oct 31, 2023 07:30AM
Aug 2, 2023 07:30AM
Feb 27, 2023 07:30AM
Jan 24, 2023 07:32AM
Jan 24, 2023 07:30AM
Nov 17, 2022 06:21AM Cantor Fitzgerald Starts Kempharm (KMPH) at Overweight
Nov 9, 2022 04:23PM
Nov 9, 2022 04:05PM
Nov 1, 2022 07:30AM
Aug 11, 2022 04:59PM
Aug 11, 2022 04:05PM
Aug 4, 2022 07:30AM
May 16, 2022 05:20AM KemPharm (KMPH) Acquires Arimoclomol from Orphazyme
May 15, 2022 08:00PM
May 4, 2022 04:30PM
Mar 30, 2022 04:05PM
Mar 10, 2022 07:30AM
Jan 19, 2022 04:22PM
Jan 19, 2022 04:21PM
Nov 10, 2021 04:05PM KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates
Nov 3, 2021 09:22AM
Aug 12, 2021 04:05PM
Aug 5, 2021 07:30AM
May 13, 2021 04:05PM
May 6, 2021 04:30PM
Mar 11, 2021 04:25PM
Mar 9, 2021 07:30AM KemPharm to Report Fourth Quarter and Full Year 2020 Financial Results
Oct 29, 2020 04:05PM
Oct 26, 2020 08:30AM
Aug 12, 2020 04:05PM
Aug 4, 2020 07:30AM
May 12, 2020 04:05PM
May 6, 2020 04:15PM
Feb 28, 2020 07:30AM KemPharm Reports Fourth Quarter and Full-Year 2019 Financial Results
Nov 14, 2019 04:55PM
Nov 12, 2019 08:30AM
Aug 13, 2019 05:00PM
May 14, 2019 04:05PM
Feb 28, 2019 04:05PM
Feb 21, 2019 04:15PM
Nov 21, 2018 08:55AM Analysis: Positioning to Benefit within KemPharm, Bellerophon Therapeutics, Exela Technologies, Intec Pharma, Cerecor, and Chiasma — Research Highlights Growth, Revenue, and Consolidated Results
Nov 15, 2018 01:46PM
Nov 8, 2018 04:05PM
Nov 1, 2018 07:30AM
Oct 5, 2018 09:32AM
Aug 9, 2018 04:05PM
Jul 31, 2018 07:30AM
May 10, 2018 04:05PM KemPharm Announces Positive, Topline Results from an Intravenous Human Abuse Potential Trial with KP415 Prodrug; Reports Q1 2018 Results
May 1, 2018 07:30AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All